The Journal of Neurology, Neurosurgery, and Psychiatry (JNNP) publishes important papers covering the whole field of clinical neurological practice. Emphasis is given to common disorders such as cerebrovascular disease, multiple sclerosis, Parkinson's disease, peripheral neuropathy, epilepsy, subarachnoid haemorrhage, including papers concerning pathogenesis and treatment. Only high priority articles are published in the journal.

The Journal of Neurology, Neurosurgery, and Psychiatry is published by the BMJ Publishing Group Ltd.

The Journal of Neurology, Neurosurgery, and Psychiatry publishes original articles, short reports, editorials, commentaries and more, covering the whole field of clinical neurological practice, neurosurgery and neuropsychiatry. Emphasis is given to common disorders such as cerebrovascular disease, multiple sclerosis, Parkinson's disease, peripheral neuropathy, epilepsy, and subarachnoid haemorrhage.

Neurology in Practice is a quarterly educational supplement, free to JNNP subscribers. It covers a specific common disorder in each issue. The articles are designed to fill the gap between the knowledge available from textbooks and journal articles and its implementation in everyday clinical practice; they are all commissioned from leading international experts.

Articles should be of direct relevance to clinical practise. Thus we do not generally publish research based on animal experiments nor studies of normal nervous system function. We do publish papers on cognitive neuropsychology if they are of clinical, as opposed to purely theoretical interest. Paediatric papers will be considered if of general interest and relevant to adult neurology. Novel mutations in known disease related genes are unlikely to be published unless they relate to a new phenotype or provide new pathophysiological information.

The JNNP publishes a small number of quality of life and health economic papers where these are of general interest, thus it is unlikely we would publish a health economic paper that was limited to only one health system or economy.

We aim to make an early decision of suitability for the journal with the result that around 50% of papers are rejected without going out to review following in house discussion. This decision would normally be made within a week of submission. Following review the decision to accept the paper for publication or to invite revision is made at a weekly editorial committee meeting.

Please click here to view the Impact Factor.

1. Median time from submission to first decision = 5 weeks
   1. 50% of papers rejected without external peer review within 1 week
2. Time from acceptance to publication = 4 months
   1. Full original articles published Online First within 2 weeks